City of Hope is turning science into practical benefit…For our current and future patients and our community
City of Hope Leads the Way in Research  
Jeffrey Weitzel, M.D. is Chief of the Division of Clinical Cancer Genetics at City of Hope. Dr. Weitzel's multidisciplinary clinical and research program emphasizes the recognition and assessment of people at increased risk for developing cancer because of family cancer history or personal risk factors. He is currently studying the incidence of breast cancer in Latina women. Learn more about Dr. Weitzel.
Amrita Krishnan, M.D., F.A.C.P., is Director of the Multiple Myeloma Program at City of Hope. Her work highlights the need for personalization in the treatment of multiple myeloma — the key is to tailor the therapy in the most appropriate way. Learn more about Dr. Krishnan.
Reducing Health Disparities
Population Sciences
The mission of the Department of Population Sciences is to advance the science and application of cancer etiology, prevention and outcomes, and reduce the burden of cancer and its sequelae across all populations, through collaborative multidisciplinary programs in clinical service, research and education. It’s divisions include Cancer Etiology, Center for Cancer Survivorship, CCARE, Clinical Cancer Genetics, Nursing Research and Education, Outcomes Research, and BMT Study.
Center of Community Alliance for Research and Education
CCARE implements specific best practice community strategies to reduce and eliminate inequalities in cancer outcomes. Our mission is to increase education and awareness of the most advanced practices in health care for all patients, bringing the best that City of Hope has to offer to underrepresented and underserved patients and communities.
Clinical Trials
At any given time, our researchers are conducting hundreds of clinical trials to test new treatments for cancer. Recruiting diverse participants to these trials allows us to better understand how cancer and its treatments impact different communities and people differently. Our clinical trials improve health.
Serving Our Latino Community
Given that cancer is the leading cause of death among Latinos in California, and recognizing that our primary service area is 46% Latino, we are taking more active steps to better understand and serve the Latino community. Learn more about our  Latino Strategy .
Contact us at for more information.